Somaxon Pharmaceuticals Sues Mylan

June 29, 2011

Somaxon Pharmaceuticals filed suit against Mylan over a patent related to the pharmacokinetics of doxepin.  6/28, District of Delaware, docket number unavailable.

Access to the full article is currently available to RPX members only. Please contact us if you need further information.

Related News